Skip to main content

Advertisement

Fig. 2 | Breast Cancer Research

Fig. 2

From: miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer

Fig. 2

Specific microRNAs (miRNAs) altered in patients with triple-negative breast cancer (TNBC) with lung metastases. a Hierarchical clustering represented in the heat map clearly discriminated normal breast tissues from tumors. Samples are presented in columns, and differently expressed miRNAs are presented in rows. Colored bars show the range of normalized log2 signals. b and c Venn diagram and the corresponding table describing the expression patterns of miRNAs dysregulated in patients with lung metastases and recurrence-free patients. Three miRNAs were overexpressed regardless of prognosis. Eight miRNAs were dysregulated in both metastatic (Met) and primary tumors (Tumor) in the lung metastasis group, especially miR-629-3p, which was the most upregulated (P < 0.001)

Back to article page